Merck Initiates Gardasil Detailing; Campaign To Focus On Cancer Prevention

Merck has begun detailing its pending human papilloma virus vaccine Gardasil to non-routine vaccinators, the company reported Dec. 15 during an annual business review in Whitehouse Station, N.J